{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Response is defined as a WBC \\< 15,000 and platelets \\> 75,000 at 12 weeks; toxicity is defined as a grade 3 or worse infection or non-hematologic toxicity within the first 4 weeks.","groups":[{"description":"0.8 mg/kg subcutaneously weekly for 90 days","id":"OG000","title":"Etanercept"}],"populationDescription":"No analysis as only registrant inevaluable, and trial terminated early due to poor enrollment.","reportingStatus":"POSTED","timeFrame":"12 weeks","title":"Patient Response","type":"PRIMARY"}